These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1056 related items for PubMed ID: 25087183

  • 1. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
    Li CH, Xu F, Chow S, Feng L, Yin D, Ng TB, Chen Y.
    Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis B virus X protein mutant HBxΔ127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT.
    Liu F, You X, Chi X, Wang T, Ye L, Niu J, Zhang X.
    Biochem Biophys Res Commun; 2014 Feb 07; 444(2):128-34. PubMed ID: 24434140
    [Abstract] [Full Text] [Related]

  • 3. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
    Pang R, Lee TK, Poon RT, Fan ST, Wong KB, Kwong YL, Tse E.
    Gastroenterology; 2007 Mar 07; 132(3):1088-103. PubMed ID: 17383430
    [Abstract] [Full Text] [Related]

  • 4. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
    Ching RHH, Sze KMF, Lau EYT, Chiu YT, Lee JMF, Ng IOL, Lee TKW.
    Oncotarget; 2017 Apr 04; 8(14):23507-23516. PubMed ID: 28186991
    [Abstract] [Full Text] [Related]

  • 5. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H.
    Oncotarget; 2015 Nov 10; 6(35):38093-106. PubMed ID: 26497554
    [Abstract] [Full Text] [Related]

  • 6. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].
    Fu XY, Tan DM, Hou ZH, Hu ZL, Liu GZ, Ouyang Y, Liu F.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug 10; 20(8):598-604. PubMed ID: 23207154
    [Abstract] [Full Text] [Related]

  • 7. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
    Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z, Liu R, Wu Z.
    Cell Signal; 2013 May 10; 25(5):1037-43. PubMed ID: 23376496
    [Abstract] [Full Text] [Related]

  • 8. Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells.
    Chan DW, Ng IO.
    J Pathol; 2006 Feb 10; 208(3):372-80. PubMed ID: 16353167
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus X protein binding to hepsin promotes C3 production by inducing IL-6 secretion from hepatocytes.
    Zhang M, Gu J, Zhang C.
    Oncotarget; 2016 Feb 16; 7(7):7780-800. PubMed ID: 26760961
    [Abstract] [Full Text] [Related]

  • 10. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis.
    Ma NF, Lau SH, Hu L, Xie D, Wu J, Yang J, Wang Y, Wu MC, Fung J, Bai X, Tzang CH, Fu L, Yang M, Su YA, Guan XY.
    Clin Cancer Res; 2008 Aug 15; 14(16):5061-8. PubMed ID: 18698024
    [Abstract] [Full Text] [Related]

  • 11. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.
    Qiu X, Dong S, Qiao F, Lu S, Song Y, Lao Y, Li Y, Zeng T, Hu J, Zhang L, Zhang L, Fan H.
    Oncogene; 2013 Jul 04; 32(27):3296-305. PubMed ID: 23604124
    [Abstract] [Full Text] [Related]

  • 12. Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma.
    Sun Q, Wang R, Wang Y, Luo J, Wang P, Cheng B.
    Oncol Rep; 2014 Feb 04; 31(2):933-9. PubMed ID: 24336972
    [Abstract] [Full Text] [Related]

  • 13. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G, Chen X, Chen S, Ye W, Hou K, Liang M.
    J Transl Med; 2016 May 05; 14(1):122. PubMed ID: 27150195
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro.
    Wu G, Yu F, Xiao Z, Xu K, Xu J, Tang W, Wang J, Song E.
    Br J Cancer; 2011 Jun 28; 105(1):146-53. PubMed ID: 21629246
    [Abstract] [Full Text] [Related]

  • 15. USP16 Downregulation by Carboxyl-terminal Truncated HBx Promotes the Growth of Hepatocellular Carcinoma Cells.
    Qian Y, Wang B, Ma A, Zhang L, Xu G, Ding Q, Jing T, Wu L, Liu Y, Yang Z, Liu Y.
    Sci Rep; 2016 Sep 16; 6():33039. PubMed ID: 27633997
    [Abstract] [Full Text] [Related]

  • 16. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
    Li J, Dai X, Zhang H, Zhang W, Sun S, Gao T, Kou Z, Yu H, Guo Y, Du L, Jiang S, Zhang J, Zhou Y.
    Oncotarget; 2015 Oct 06; 6(30):29196-208. PubMed ID: 26470691
    [Abstract] [Full Text] [Related]

  • 17. C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.
    Ng KY, Chai S, Tong M, Guan XY, Lin CH, Ching YP, Xie D, Cheng AS, Ma S.
    Oncotarget; 2016 Apr 26; 7(17):24005-17. PubMed ID: 27006468
    [Abstract] [Full Text] [Related]

  • 18. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS, Su ZR, Lee YP, Liu IT, Yen CJ.
    World J Gastroenterol; 2016 Jun 14; 22(22):5183-92. PubMed ID: 27298561
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B virus X protein and c-Myc cooperate in the upregulation of ribosome biogenesis and in cellular transformation.
    Shukla SK, Kumar V.
    FEBS J; 2012 Oct 14; 279(20):3859-71. PubMed ID: 22889122
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack.
    Shan C, Zhang S, Cui W, You X, Kong G, Du Y, Qiu L, Ye L, Zhang X.
    Carcinogenesis; 2011 Aug 14; 32(8):1190-7. PubMed ID: 21665888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.